Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Experimental Study Shows that Learned Immunosuppressive Placebo Responses Attenuate Disease Progression in a Rat Model of Arthritis
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Experimental Study Shows that Learned Immunosuppressive Placebo Responses Attenuate Disease Progression in a Rat Model of ArthritisOctober 1, 2019
Neuroendocrine Immune Implications in Rheumatoid Arthritis and Polymyalgia Rheumatica: Past and Present Unresolved Issues and Optimising Glucocorticoid TreatmentDecember 8, 2018
Norepinephrine through β2-adrenoceptor activation down-regulates pro-inflammatory pathogenic Th17 cells in a rodent model of rheumatoid arthritisMarch 20, 2018
Gut and Gingival Bacteria: Game Changers or Innocent Bystanders in Rheumatoid Arthritis?April 4, 2017
Vasoactive Intestinal Peptide Inhibits Pathogenic Th17 Cells from Rheumatoid Arthritis PatientsMay 27, 2015
Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor Agonists in a Murine Model of Rheumatoid ArthritisMarch 11, 2015
The Cross-talk between the Dopaminergic System and Innate Immunity: An Evolving ConceptMarch 27, 2018
Afferent Vagus Nerve Stimulation Activates Brain Locus Coeruleus and Improves Experimental Joint InflammationJuly 18, 2017
New Evidence Suggests Targeting Neuroinflammation May Be One Key to Slowing Alzheimer’s DiseaseAugust 16, 2016
Vitamin D Deficiency May Contribute to the Reduction of Sympathetic and Sensory Innervation in ArthritisMay 8, 2015
Blood Levels of the New Anti-Inflammatory Cytokine IL-37 Are Increased In Rheumatoid Arthritis PatientsFebruary 24, 2015
